Featured Research

from universities, journals, and other organizations

Neurons made from stem cells drive brain activity after transplantation in laboratory model

Date:
November 15, 2012
Source:
Sanford-Burnham Medical Research Institute
Summary:
Scientists are able to make neurons and other brain cells from stem cells, but getting these neurons to properly function when transplanted to a host has proven more difficult. Now, researchers have found a way to stimulate stem cell-derived neurons to direct cognitive function after transplantation to an existing neural network.

Illustration of a neural network. Researchers have found a way to stimulate stem cell-derived neurons to direct cognitive function after transplantation to an existing neural network.
Credit: © nobeastsofierce / Fotolia

Researchers and patients look forward to the day when stem cells might be used to replace dying brain cells in Alzheimer's disease and other neurodegenerative conditions. Scientists are currently able to make neurons and other brain cells from stem cells, but getting these neurons to properly function when transplanted to the host has proven to be more difficult. Now, researchers at Sanford-Burnham Medical Research Institute have found a way to stimulate stem cell-derived neurons to direct cognitive function after transplantation to an existing neural network.

The study was published November 7 in the Journal of Neuroscience.

"We showed for the first time that embryonic stem cells that we've programmed to become neurons can integrate into existing brain circuits and fire patterns of electrical activity that are critical for consciousness and neural network activity," said Stuart A. Lipton, M.D., Ph.D., senior author of the study. Lipton is director of Sanford-Burnham's Del E. Webb Neuroscience, Aging, and Stem Cell Research Center and a clinical neurologist.

The trick turned out to be light. Lipton and his team -- including Juan Piña-Crespo, Ph.D., D.V.M., Maria Talantova, M.D., Ph.D., and other colleagues at Sanford-Burnham and Stanford University -- transplanted human stem cell-derived neurons into a rodent hippocampus, the brain's information-processing center. Then they specifically activated the transplanted neurons with optogenetic stimulation, a relatively new technique that combines light and genetics to precisely control cellular behavior in living tissues or animals.

To determine if the newly transplanted, light-stimulated human neurons were actually working, Lipton and his team measured high-frequency oscillations in existing neurons at a distance from the transplanted ones. They found that the transplanted neurons triggered the existing neurons to fire high-frequency oscillations. Faster neuronal oscillations are usually better -- they're associated with enhanced performance in sensory-motor and cognitive tasks.

To sum it up, the transplanted human neurons not only conducted electrical impulses, they also roused neighboring neuronal networks into firing -- at roughly the same rate they would in a normal, functioning hippocampus.

The therapeutic outlook for this technology looks promising. "Based on these results, we might be able to restore brain activity -- and thus restore motor and cognitive function -- by transplanting easily manipulated neuronal cells derived from embryonic stem cells," Lipton said.


Story Source:

The above story is based on materials provided by Sanford-Burnham Medical Research Institute. The original article was written by Heather Buschman. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. C. Pina-Crespo, M. Talantova, E.-G. Cho, W. Soussou, N. Dolatabadi, S. D. Ryan, R. Ambasudhan, S. McKercher, K. Deisseroth, S. A. Lipton. High-Frequency Hippocampal Oscillations Activated by Optogenetic Stimulation of Transplanted Human ESC-Derived Neurons. Journal of Neuroscience, 2012; 32 (45): 15837 DOI: 10.1523/JNEUROSCI.3735-12.2012

Cite This Page:

Sanford-Burnham Medical Research Institute. "Neurons made from stem cells drive brain activity after transplantation in laboratory model." ScienceDaily. ScienceDaily, 15 November 2012. <www.sciencedaily.com/releases/2012/11/121115152657.htm>.
Sanford-Burnham Medical Research Institute. (2012, November 15). Neurons made from stem cells drive brain activity after transplantation in laboratory model. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2012/11/121115152657.htm
Sanford-Burnham Medical Research Institute. "Neurons made from stem cells drive brain activity after transplantation in laboratory model." ScienceDaily. www.sciencedaily.com/releases/2012/11/121115152657.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:  

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile iPhone Android Web
      Follow Facebook Twitter Google+
      Subscribe RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins